Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Blin

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Neurology|January 1, 1992
Decreased cerebral glucose utilization in myotonic dystrophyM Fiorelli, D Duboc, B M Mazoyer, et al.
Advances in Neurology|January 1, 1990
The efficacy of levodopa treatment declines in the course of Parkinson's disease: do nondopaminergic lesions play a role?Y Agid, A M Graybiel, M Ruberg, et al.
Journal of Neurochemistry|May 1, 1990
A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperoneJ Blin, G Sette, M Fiorelli, et al.
Neuroimage|February 7, 1998
Cholinergic neurotransmission has different effects on cerebral glucose consumption and blood flow in young normals, aged normals, and Alzheimer's disease patientsJ Blin, A Ivanoiu, A Coppens, et al.
Schizophrenia Research|June 20, 1998
No serotonin 5-HT2A receptor density abnormality in the cortex of schizophrenic patients studied with PETC Trichard, M L Paillère-Martinot, D Attar-Levy, et al.
Annals of Neurology|October 1, 1991
Somatostatin replacement therapy for Alzheimer dementiaM M Mouradian, J Blin, M Giuffra, et al.
Brain : a Journal of Neurology|December 1, 1995
Does the enhancement of cholinergic neurotransmission influence brain glucose kinetics and clinical symptomatology in progressive supranuclear palsy?J Blin, P Mazetti, B Mazoyer, et al.
Brain Research|January 28, 1994
Comparison of cholinergic drug effects on regional brain glucose consumption in rats and humans by means of autoradiography and position emission tomographyJ Blin, C A Ray, M F Piercey, et al.
Journal of the Neurological Sciences|September 1, 1988
D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsyL Pierot, C Desnos, J Blin, et al.
Brain Research|March 7, 1997
Brain energy metabolism in early blind subjects: neural activity in the visual cortexA G De Volder, A Bol, J Blin, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Neurology|January 1, 1992
Decreased cerebral glucose utilization in myotonic dystrophyM Fiorelli, D Duboc, B M Mazoyer, et al.
Advances in Neurology|January 1, 1990
The efficacy of levodopa treatment declines in the course of Parkinson's disease: do nondopaminergic lesions play a role?Y Agid, A M Graybiel, M Ruberg, et al.
Journal of Neurochemistry|May 1, 1990
A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperoneJ Blin, G Sette, M Fiorelli, et al.
Neuroimage|February 7, 1998
Cholinergic neurotransmission has different effects on cerebral glucose consumption and blood flow in young normals, aged normals, and Alzheimer's disease patientsJ Blin, A Ivanoiu, A Coppens, et al.
Schizophrenia Research|June 20, 1998
No serotonin 5-HT2A receptor density abnormality in the cortex of schizophrenic patients studied with PETC Trichard, M L Paillère-Martinot, D Attar-Levy, et al.
Annals of Neurology|October 1, 1991
Somatostatin replacement therapy for Alzheimer dementiaM M Mouradian, J Blin, M Giuffra, et al.
Brain : a Journal of Neurology|December 1, 1995
Does the enhancement of cholinergic neurotransmission influence brain glucose kinetics and clinical symptomatology in progressive supranuclear palsy?J Blin, P Mazetti, B Mazoyer, et al.
Brain Research|January 28, 1994
Comparison of cholinergic drug effects on regional brain glucose consumption in rats and humans by means of autoradiography and position emission tomographyJ Blin, C A Ray, M F Piercey, et al.
Journal of the Neurological Sciences|September 1, 1988
D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsyL Pierot, C Desnos, J Blin, et al.
Brain Research|March 7, 1997
Brain energy metabolism in early blind subjects: neural activity in the visual cortexA G De Volder, A Bol, J Blin, et al.
Pageof 4